Skip to main content
JBS logo

JBS · Jbs N.V.

Track JBS — free
$13.65 +0.33 (+2.48%)
Market Cap
$14.26B
Shares
1.07B

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.32 Open$13.18 Day$13.13–13.52 52W close$11.62–18.42 Avg vol 30d5.4M Short int35.2M · 3.3% float · 6.6d Short vol62% Last earningsNov 9, 2026 DataJun 2025–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 9, 2026 Scheduled · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 10, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Moderate
Market backdrop VIX 14.6 · calm Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −8%
below
Price vs 50-day avg +6%
above
RSI (14) 53
neutral
MACD trend Negative
52-week position 25%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +11%
trailing
6-month return −18%
trailing
YTD return −8%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $13 › 200d $14 — 200d above 50d
Institutional flow Accumulating
216 of 253 funds reported for Jun 30 · net +31.6M sh shares · +47 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.29% of float · ▲ +10.4% MoM · 6.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
253 holders — near 2-yr high, broad support
Squeeze score 59
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Moderate
Volatility 34%
annualized · 1-yr
Max drawdown −37%
past year
ATR 3.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2025
For 2026
Capital expenditures $2.4B
2026
Interest expenses $1.15B
Leasing expenses $500M
Consolidated effective tax rate 25%
Prior guidance period ended · from the Earnings Call filed Jun 30, 2025
Capital expenditures · 2025 $2B
Working capital · 2025 $900M
Legal settlements · 2025 $300M
Biological assets · 2025 $650M
Leasing expenses · 2025 $500M
Interest expenses · 2025 $1.15B

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−8% Bearish
Price vs 50-day avg
+6% Bullish
RSI (14)
53 Neutral
MACD trend
Negative Bearish
52-week position
25% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $13 › 200d $14 — 200d above 50d
Institutional flow Accumulating
216 of 253 funds reported for Jun 30 · net +31.6M sh shares · +47 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.29% of float · ▲ +10.4% MoM · 6.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
253 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $12 Now $13 · 25% Range high $18
vs 200-day avg -8% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Earnings Per Share Attributable to JBS non-GAAP $0.43 Six Months Ended 2026
Adjusted EBITDA USGAAP non-GAAP $1.26B 2Q26
GAAP → non-GAAP reconciliation
GAAP Adjusted EBITDA (IFRS) 1.43B
-85.9M Leasing adjustments
-18.6M Inventory adjustments at market value
-68.6M Biological assets adjustments
+0.3M Other adjustments
= Adjusted EBITDA (USGAAP) 1.26B
Adjusted Net income Attributable to JBS non-GAAP $459.6M Six Months Ended 2026
Adjusted Operating Income IFRS non-GAAP $790.2M 2Q26
GAAP → non-GAAP reconciliation
GAAP Total Adjusted EBITDA 1.43B
-639.1M (-) Depreciation and amortization
= Adjusted Operating Income (IFRS) 790.2M
Adjusted Operating Income USGAAP non-GAAP $865.9M 2Q26
GAAP → non-GAAP reconciliation
GAAP Adjusted Operating Income IFRS 790.2M
-16.5M Leasing adjustments
-18.6M Inventory adjustments at market value
+110.1M Biological assets adjustments
+0.6M Other adjustments
= Adjusted Operating Income (USGAAP) 865.9M
Free Cash Flow $36.4M Six Months Ended 2026
Gross Debt/Adjusted EBITDA 3.71 2Q26
Interest Coverage 5 Last twelve months ended June 30, 2026
ROE 13.4% Last twelve months ended June 30, 2026
ROIC 13.4% Last twelve months ended June 30, 2026
Total Adjusted EBITDA non-GAAP $6.11B Last twelve months ended June 30, 2026
Total Gross Debt $22.65B 2Q26
Total Net Debt $18.96B 2Q26

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
JBS
Jbs N.V.
this stock
$14.26B -7.6% 3.3%
KHC
Kraft Heinz Co
$30.10B +4.7% -0.1% 7.3%
GIS
General Mills Inc
$20.77B -16.3% +4.1% 9.2%
MKC
Mccormick & Co Inc
$14.24B -20.1% +1.7% 8.8 5.1%
HRL
Hormel Foods Corp /De/
$13.45B +3.1% +1.6% 28.8 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
275
% held
38.9%
Reported
216 of 253
Top holder
BNDES Participacoes S.A.
Held Float
View
Held by Funds
Fund positions
57
View
Short & Settlement
Short Interest Rising
Shares short
35.2M
Days to cover
6.6d
Change
+3.3M sh
View
Short Volume
Short vol %
62%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
5.3K
Value
$64.8K
As of
Jul 7, 2026
View
Off-Exchange
Off-exchange %
40.6%
Week of
Jul 6, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 11, 2026
This year
19
View
Earnings & Events
Earnings Calls Upcoming
Next call
Nov 9, 2026
Last call
Aug 11, 2026
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
JBS -2.7% +10.7% -18.2% -5.0% -7.6%
SPY +1.2% +3.6% +12.8% +4.1% +14.1%
vs SPY -3.9% +7.1% -31.1% -9.1% -21.7%

Capital returns

Latest dividend
$1.00 / share · ex May 18, 2026
Paid (TTM)
$1.00 / share · 1 payout
Dividend yield (TTM, derived)
· history filling in

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1791942 CUSIP N4732M103 13F (30d) 183 filings 180 filers Visit website Investor relations